Cancer Proteomics

Proteomics based techniques allow the description of biomarkers and protein expression signatures, which are used to anticipate responses to drugs and the clinical course of disease, and such advice could be used to analyze therapy. Indeed, proteomics and imaging technologies are being associated to advance diagnostics, histological grading of tumours and responses to therapy. Such breakthrough is integrated by huge number of clinical samples being accumulate in biobanks, which allows researchers to screen large cohorts and approve their findings.

Relevant Conferences:

Conference on Pancreatic & Colorectal Cancer during March 29-30, 2016 Atlanta, USA; 2nd International Conference on Prostate Cancer & Treatment during May 05-07, 2016 Chicago, USA; Cancer Diagnostics Conference and Exhibition during June 13-15, 2016 Rome, Italy; Conference on Cancer Immunology & Immunotherapy during July 28-30, 2016 Melbourne, Australia; Conference on Thyroid Cancer & Treatment during August 01-03, 2016 Toronto, Canada; European Lung Cancer Conference during April 13-16, 2016 Geneva, Switzerland; Breast Cancer Conference during May 12-14, 2016 Brussels, Belgium; World Congress on Gastrointestinal Cancer 2016 during June 29-July 02, 2016 Barcelona, Spain; Symposium on Immuno Oncology 2016 during November 04-05, 2016 Lausanne, Switzerland.

A cancer biomarker refers to a substance or process that is indicative of the presence of cancer in the body. A biomarker may be a molecule secreted by a tumor or a specific response of the body to the presence of cancer. Proteomic technologies hold recently great promise in the search of new clinical biomarkers for the early detection and diagnosis of cancer as well as the discovery of new therapeutic targets from accessible bio-specimens. Cancer systems biology encompasses the application of systems biology approaches to cancer research, in order to study the disease as a complex adaptive system with emerging properties at multiple biological scales.

  • Cancer biomarker discovery
  • Proteomics in cancer diagnosis
  • Quantitative proteomics in cancer systems biology

Related Conference of Cancer Proteomics

September 18-20, 2017

9th International Conference on Structural Biology

Zurich, Switzerland
September 21-22, 2017

International Conference on Glycobiology

Houston, Texas, USA
September 28-29, 2017

2nd International Conference on Biochemistry

Dubai, UAE
October 16-17, 2017

3rd Annual Congress on Bioscience

Dubai,UAE
October 18-19, 2017

10th Annual Chemistry Congress

Osaka, Japan
October 25-26, 2017

Global Proteomics Conference

Dubai, UAE
October 30 - November 01, 2017

3rd International Conference on Transcriptomics

Bangkok, Thailand
November 8-9, 2017

International Summit on Nanotechnology and Medical Robots

New Orleans, Louisiana, USA
November 13-14, 2017

9th International Conference on Bioinformatics

Paris, France
March 19-20, 2018

12th Global
Gastroenterologists Meeting

Barcelona, Spain
19-20 March ,2018

23rd World Cardiology Conference

Dubai,UAE
April 13-15, 2018

19th International Congress on Nutrition & Health

Amsterdam, Netherlands
April 19-20, 2018

3rd World Heart Congress

Amsterdam, Netherlands
April 23-24, 2018

International Conference on Internal Medicine

Dubai, UAE
August 06-07, 2018

18th International Conference on Pediatrics Health

Madrid, Spain
July 16-18, 2018

World Congress on Green Chemistry and Green Engineering

Melbourne, Australia
May 14-16, 2018

Global Congress on Asthma and Allergy

Singapore
August 22-23, 2018

5th Asia Pacific Gynecology and Obstetrics Congress

Tokyo, Japan
August 29-31, 2018

17th World Congress on Clinical Nursing and Practice

Zurich, Swtizerland
September 17-19, 2018

4th Glycobiology World Congress

Rome, Italy

Cancer Proteomics Conference Speakers

Recommended Sessions

Related Journals

Are you interested in